COVID-19 Records

Gates Package — page 40

of 1375 pages

← p.39 p.41 → · this page in the original PDF · package

www.cbrintl.com<http://www.cbrintl.com/> This electronic transmission (including any and all attachments) is intended solely for the use of the individual or entity to whom it is addressed and may contain information that is privileged and/or confidential. If you are not the intended recipient of this electronic transmission, you are hereby notified that any disclosure, copying or distribution, or the taking of any action in reliance upon the contents of this electronic transmission, is strictly prohibited, and you are further requested to purge this electronic transmission and all copies thereof from your computer system. On Aug 4, 2014, at 8:42 AM, "Mike Hensley" <§@icloud.com<mailto {H@ icloud.com>> wrote: Was late getting the document because of some e-mail issues but finally received. I have no additions or deletions and would consider it a fair and objective assessment of what is available on the therapeutic side of the ledger. Working on references as I'm still at Lisa's home and need to locate a couple on line. Thanks for including me. Mike Hensley On Aug 3, 2014, at 11:38 AM, "Hayden, Frederick G *HS" le hscmail.mcc.virginia.edu<mailto {jjg@hscmail.mcc.virginia.edu>> wrote: Apologies but I left the last reference off by mistake. Please add this very helpful review article: Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet 377: ; From: Trina Racine GP phiac-aspc.ge ca<mailto: BMP phac-aspc.gc.ca>] Sent: 03 August 2014 10:30 To: Hayden, Frederick G *HS Cc: BO who.int<mailto {MO who.int>; Gary (Public Health Agency of Canada) Kobinger; nih.gov<mailto: nih.gov> [C] Olinger; Peter (NIH/NIAID) [E] Jahrling; Mike Hensley; who.int<mailto: who.int>; Larry Zeitlin; Lisa (NIH/NIAID) [E] Hensley; Miles Brennan; Marshall Hoke; Ho who. int<mailto {j@who.int>; deborah scott; Shindo, Nikki; HR @ cm ail.com<mailto HO email.com> ; Tara Nyhuis Subject: RE: Combining the existing Phase 1 with a Therapeutic Portion Hello Frederick, Please find attached an edited version of the document (only very minor edits). The document is very well done and provides a nice overview of what is available. The document I received however did not contain sections 5 and higher as listed in the Content section (not sure if this was intentional or not). Thanks, Trina From: "Hayden, Frederick G *HS" <{@hscmail.mcc.virginia.edu<mailtofjj@hscmail.mcc.virginia.edu>>

This is our OCR of the page, with running headers and footers removed. The Committee's PDF is authoritative; quote from it. Machine-readable, including the uncleaned text: /api/page/gates/40

Records on this page

RecordDateTypePages
RE: Combining the existing Phase 1 with a Therapeutic Portion 2014-08-03 email 40–42
gates:email:00010 2014-08-03 email 40
gates:email:00009 2014-08-05 email 39–40